Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:2.7.7.49 (reverse transcriptase)
31,746 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Published nucleotide sequence data for IBDV variant viruses (A and 1048E) and classic viruses (STC, 52-70, PBG98, Cu-1, and 002-73) were used to identify restriction enzyme sites that could potentially be used to differentiate these strains of IBDV. To test this hypothesis, the genomes of IBDV strains STC, MD, NC, and OH were converted to cDNA using reverse transcriptase (RT) and then amplified using the polymerase chain reaction (PCR). The PCR primers were selected from relatively conserved sequence regions in the VP2 gene, and they were used to amplify a 394-base-pair fragment. The restriction enzymes (RE) DraI, EcoRII, SacI, Sau3AI, StyI, and TaqI were tested for their ability to digest the RT/PCR products. The STC classic virus was SacI-, StyI-, and EcoRII-positive and DraI-, Sau3AI-, and TaqI-negative. The MD, NC, and OH viruses were DraI-, Sau3AI-, and TaqI-positive and SacI-, StyI-, and EcoRII-negative. The classic STC strain could be differentiated from the variant MD strain using the RT/PCR-RE assay. Based on these results and the presence or absence of other restriction sites that were predicted by published nucleotide sequence data, the RT/PCR-RE assay has the potential to differentiate IBDV isolates MD, A, and 1048E. Published nucleotide sequence data and the RT/PCR-RE results obtained using STC and MD indicated that variant viruses MD, A, and 1048E could be differentiated from classic viruses STC, 52-70, PBG98, Cu-1, 002-73, and NC.
...
PMID:Infectious bursal disease viruses: molecular differentiation of antigenic subtypes among serotype 1 viruses. 783 6

Human membrane cofactor protein (MCP, CD46) is a receptor for the measles virus and serves as a complement regulator which protects host cells from autologous complement attack. MCP is highly polymorphic due to a variety of mRNA splice products. The levels of MCP expression on T and myeloid cell lines are usually two-eightfold higher than those on their normal counterparts, whereas Burkitt's lymphoma B cell lines express less MCP than B cell lineages carrying no EB virus. The molecule has a Ser/Thr-rich (ST) domain adjacent to the functional domain, namely short consensus repeats (SCR). The ST domain and a cytoplasmic tail (CYT) contribute to the MCP polymorphism. The ST domain is encoded by three exons (A, B and C) and major ST isoforms are STABC, STBC and STC. The authors investigated the relationship between the expression levels and isoform usage of MCP by flow cytometry using specific antibodies against STA and STC, by reverse transcriptase-polymerase chain reaction (RT-PCR) with size markers for each splice variant, and by RT-PCR/Southern blotting using a specific probe for STA. The results were (1) the profiles of mean shifts of myeloid and T cell lines were STC < STA on flow cytometry while those of B cell lines and normal blood cells were STA < STC; (2) all cell lines tested by RT-PCR expressed the messages for the isoforms STBC/CYT1, STC/CYT1, STBC/CYT2, and STC/CYT2. The band for STABC/CYT2 overlapped that for STC/CYT1, and the band for STABC/CYT1 was marginal in all cell lines examined; (3) semi-quantitative analysis of the STABC isoforms by Southern blotting indicated the presence of high levels of the STABC messages in myeloid and T-cell lines in comparison with B lymphoid cells and normal leucocytes. Thus, the quantity of MCP expressed parallels the STABC message level, which is up-regulated in T and myeloid leukaemia cell lines.
...
PMID:High expression of membrane cofactor protein of complement (CD46) in human leukaemia cell lines: implication of an alternatively spliced form containing the STA domain in CD46 up-regulation. 855 81

The preservation of viable infectious agents for future studies could create complicated logistic problems, and at times it is not feasible. Methods for preserving the genetic integrity of inactivated agents would not only facilitate these studies but would also make it possible to transport inactivated preparations around the world. In this report, the effect of inactivation on the genetic material of infectious bursal disease virus (IBDV) was studied. Tissues from the bursa of Fabricius of birds experimentally infected 3 days earlier with the classic STC strain of IBDV were collected and immediately placed in a solution of phenol:chloroform:isoamyl alcohol (25:24:1) for 24, 48, 72, or 96 hr. Infected bursal tissue not treated with the phenol:chloroform solution and uninfected phenol: chloroform bursal tissue were used as controls. In a separate experiment, bursal tissues collected 5 days following infection of specific-pathogen-free birds with the classic STC or variant 1084-E strain were placed in the phenol:chloroform solution for 2 wk. All bursal samples were tested for viable IBDV following phenol:chloroform treatment. The tissues were washed in phosphate-buffered saline to remove phenol and then homogenized. Viability of the viruses in homogenized bursal tissue was examined by inoculation of embryonated chicken eggs. Viable IBDV was not observed in any phenol:chloroform-treated bursal tissue but was observed in the infected but non-phenol:chloroform-treated control bursa. The reverse transcriptase/polymerase chain reaction (RT/PCR) was used to test the integrity of the viral RNA. Viral RNA from the nontreated control and all infected bursal samples treated with phenol:chloroform solution at all the time points examined were transcribed into DNA, and a 394-bp fragment of the VP2 gene was amplified using specific primers in the PCR. The RT/PCR assay was negative using the phenol:chloroform-treated uninfected bursal tissue. This study clearly demonstrated that phenol:chloroform treatment of infected bursal tissue inactivated the classic and variant IBDV strains tested and preserved the viral RNA for use in the RT/PCR assay.
...
PMID:Infectious bursal disease viral RNA amplification using RT/PCR from bursa tissue following phenol: chloroform inactivation of the virus. 879 Aug 99

The variant MD strain of infectious bursal disease virus (IBDV) was examined using restriction fragment length polymorphism (RFLP) and the molecular variation was compared with published sequences of both variant and classic IBDV strains. Viral RNA was transcribed into cDNA using reverse transcriptase and then amplified by the polymerase chain reaction (PCR). Three separate but overlapping fragments of 1603 bp, 1496 bp, and 1066 bp containing the entire coding region for VP2, VP4, and VP3, respectively, were amplified. These amplified products were initially cloned using the TA Cloning kit and further subcloned into the pGEM-3Zf and pUC19. Eight restriction enzymes, PstI, BamHI, AvaI, EcoRI, HindII, XmaI, SmaI, and XbaI, were tested for their ability to digest the MD PCR products. The resulting RFLP was analyzed and compared with the published genome segment A sequences of the classic IBDV strain STC and the variant IBDV strain GLS. Differences in restriction fragment profiles were observed after digestion with BamHI, EcoRI, XmaI, and SmaI, with the absence of the EcoRI site in both variant strains, GLS and MD. The MD PCR products lacked both XmaI and SmaI sites, which were present in both STC and GLS. The MD PCR products contained a BamHI site within the hypervariable region of VP2, which is present in STC but not in the variant GLS. An additional BamHI site was identified in the VP4 gene of MD and GLS but not in STC.
...
PMID:Restriction analysis of the MD infectious bursal disease virus strain. 898 Aug 28

Twenty-two infectious bursal disease virus (IBDV) strains were examined using the reverse transcriptase/polymerase chain reaction-restriction endonuclease (RT/PCR-RE) assay. A 394-bp fragment of the VP2 gene was amplified and tested for six different restriction enzyme sites. Although the EcoRII enzyme was used in previous RT/PCR-RE assays, results obtained using the isoschizomer BstNI were more consistent because its activity does not rely on multiple restriction sites. Ten different RT/PCR-RE profiles were observed. IBDV strains previously reported to be variant type viruses were BstNI and StyI negative except variant strain IN. The Bursine, Bursine-2, Bursine-Plus and Bio-Burs viruses were BstNI negative. The presence of a second enzyme site, StyI, was observed in these viruses and could be used to differentiate them from the known variant viruses, which were StyI negative. Nucleotide sequence data also indicated that these viruses were not identical to variant or classic type viruses. The base substitution observed in the BstNI site of Bio-Burs and Bursine-2 was responsible for changing the amino acid at position 222 to serine. The amino acid at this position has been reported to influence a neutralizing epitope on VP2. Three IBDV strains were examined after propagation in different hosts. The RE profiles of the STC and MD IBDV strains did not change after propagation in either BGM-70 cell culture or chicken bursas, whereas the Del-A RE profile changed at the Sau3AI site after adaptation to BGM-70 cell culture. This site has not been associated with antigenic or other phenotypic characteristics of IBDV.
...
PMID:Molecular identification of infectious bursal disease virus strains. 908 25

Genomic segment A of the variant infectious bursal disease virus (IBDV) strain MD was amplified by reverse transcriptase/polymerase chain reaction and further characterized by baculovirus expression. Three different baculovirus clones were constructed containing the genes encoding VP2, VP2/VP4, and the complete polyprotein cloned into the baculovirus transfer vector pVL1392. Baculovirus recombinants were identified by dot blot hybridization and were plaque purified three times. Baculovirus expression of the recombinants produced IBDV-specific proteins that were comparable in molecular size to native MD IBDV viral proteins VPX (48 kD), VP2 (45 kD), VP3 (32 kD), and VP4 (28 kD) as determined by sodium dodecyl sulfare-polyacrylamide gel electrophoresis and western immunoblot analysis. All three recombinants produced a 48-kD protein that possibly represents VPX, the precursor product of VP2. In addition to the 48-kD protein, the VP2/VP4 recombinant produced an IBDV-specific protein corresponding to the 28-kD VP4. The baculovirus-expressed polyprotein gene produced, in addition to the 48-kD protein, a 32-kD (VP3) IBDV-specific protein and a 29-kD protein that migrated slightly slower than MD VP4. The baculovirus-expressed proteins were used as antigens in an indirect enzyme-linked immunosorbent assay (ELISA). The ELISAs detected antibodies against the variant IBDV strains MD, GLS, and IN and the classic IBDV strains SAL and STC but did not detect antibodies against the variant Del-A and classic IBDV strain BVM or the serotype 2 IBDV strain OH.
...
PMID:Expression of MD infectious bursal disease viral proteins in baculovirus. 935 8

Genomic segment A of the variant Md infectious bursal disease virus (IBDV) was amplified by reverse transcriptase/polymerase chain reaction, cloned, and expressed in the baculovirus expression system. Three different baculovirus recombinants expressing the genes encoding VP2, VP2/VP4, and the complete polyprotein (VP2/VP4/VP3) were prepared. The three antigens were used in separate enzyme-linked immunosorbent assays, and each detected antibodies against the variant IBDV strains Md, Del-A, Del-E, and GLS and the classic IBDV strain D78 throughout a 14-wk period following vaccination. Eight-week-old specific-pathogen-free (SPF) chickens were inoculated subcutaneously using the VP2/VP4 or VP2/VP4/VP3 baculovirus recombinant or wild-type baculovirus-infected insect cell lysates. Virus-neutralizing antibodies were detected in the VP2/VP4 and VP2/VP4/VP3 baculovirus-inoculated birds at 13 days postinoculation (PI) and at 43 days PI when titrated against Md IBDV. No virus-neutralizing antibody titer was observed in the negative controls or wild-type baculovirus-inoculated birds. One-week-old SPF chickens were inoculated with the VP2, VP2/VP4/VP3 baculovirus recombinants or wild-type baculovirus-infected insect cell lysates. The birds were boosted 2 wk later and challenged at 4 wk of age with 0.5 ml/bird classic STC IBDV (10(2) median embryo infective dose [EID50]/ml) or variant Md IBDV (10(5) EID50/ml) via the oral/nasal route. The VP2 and VP2/VP4/VP3 baculovirus-inoculated birds were partially protected against challenge with the classic STC IBDV. The birds were protected against clinical disease and death but not bursal damage, whereas the wild-type baculovirus-inoculated birds exhibited clinical signs of disease, 13% mortality, and bursal damage. When challenged with the variant Md IBDV, neither the VP2, VP2/VP4/VP3 baculovirus recombinants nor the wild-type baculovirus elicited protection against bursal damage and atrophy.
...
PMID:Antigenic and immunogenic properties of baculovirus-expressed infectious bursal disease viral proteins. 953 84

Strains of highly virulent infectious bursal disease virus (HVIBDV) from Turkey (OA, OE), Holland (HOL), and Taiwan (PT, IL) were characterized by reverse transcriptase/polymerase chain reaction-restriction fragment length polymorphism (RT/PCR-RFLP) analysis and compared with the United States of America (USA) classic (STC) and variant (MD, IN) serotype 1 viruses and serotype 2 OH strain. A primer pair that amplified a 743-bp fragment of the VP2 gene was used. The RFLP profiles of the RT/PCR products were determined with four restriction enzymes (SspI, BstNI, MboI, and StyI). The SspI enzyme distinguished the HVIBDVs from the USA classic and variant viruses and the serotype 2 virus. The USA serotype 1 viruses used in this study did not have restriction sites for SspI in the 743-bp VP2 fragment. The RFLP profiles of the five HVIBDVs when digested with BstNI were different from the USA classic STC virus but were similar to the variant viruses (MD, IN). The RFLP profiles for isolates from Turkey and Holland were similar to the classic STC strain when digested with MboI but were different from the variant USA viruses (MD, IN). The RFLP profiles of the two Taiwan isolates were different from the Holland, Turkey, and USA classic and variant viruses when digested with MboI. When the five HVIBDVs were digested with StyI enzyme, their RFLP patterns were similar to those of the USA classic STC strain but were different from the USA variant viruses. None of the strains tested had patterns similar to serotype 2 OH virus.
...
PMID:Restriction fragment length polymorphism analysis of highly virulent strains of infectious bursal disease viruses from Holland, Turkey, and Taiwan. 977 47

Although a role for the gastric and intestinal mucosa in molecular sensing has been known for decades, the initial molecular recognition events that sense the chemical composition of the luminal contents has remained elusive. Here we identified putative taste receptor gene transcripts in the gastrointestinal tract. Our results, using reverse transcriptase-PCR, demonstrate the presence of transcripts corresponding to multiple members of the T2R family of bitter taste receptors in the antral and fundic gastric mucosa as well as in the lining of the duodenum. In addition, cDNA clones of T2R receptors were detected in a rat gastric endocrine cell cDNA library, suggesting that these receptors are expressed, at least partly, in enteroendocrine cells. Accordingly, expression of multiple T2R receptors also was found in STC-1 cells, an enteroendocrine cell line. The expression of alpha subunits of G proteins implicated in intracellular taste signal transduction, namely Galpha(gust), and Galpha(t)-(2), also was demonstrated in the gastrointestinal mucosa as well as in STC-1 cells, as revealed by reverse transcriptase-PCR and DNA sequencing, immunohistochemistry, and Western blotting. Furthermore, addition of compounds widely used in bitter taste signaling (e.g., denatonium, phenylthiocarbamide, 6-n-propil-2-thiouracil, and cycloheximide) to STC-1 cells promoted a rapid increase in intracellular Ca(2+) concentration. These results demonstrate the expression of bitter taste receptors of the T2R family in the mouse and rat gastrointestinal tract.
...
PMID:Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. 1185 32

Nine Spanish isolates of infectious bursal disease virus (IBDV) were characterized and classified after reverse transcriptase-polymerase chain reaction of a 248-bp fragment of the VP2 gene hypervariable region and restriction fragment length polymorphism (RFLP). The restriction endonucleases (REs) used were BstNI, Sad, SspI, TaqI, DraI, and StyI. Sequencing of the amplified product and further comparison of these sequences with published sequence data from other IBDV strains were also performed. Very virulent and classic strains were identified. None of the strains identified had molecular characteristics similar to that of the American variant strains. Four very virulent strains (VG-248, 5939, 6145, and 7333) were digested by the TaqI, SspI, and StyI enzymes. The sequences of these strains were closely related to other European and Japanese very virulent IBDV (vvIBDV) strains. Strains VG-311, VG-262, and VG-208 were digested by the BstNI and Sad REs and were classified as classic strains. Strains VG-276 and VG-313 had unique RFLP patterns. VG-276 exhibited the SspI RE site, which has been reported as a characteristic of vvIBDV strains, whereas the VG-313 strain exhibited a Sad and StyI RE site indicative of the classic IBDV Edgar and 52-70 strains. However, nucleotide sequence analysis of the amplified hypervariable region strain VG-276 revealed a higher identity with the classic strains STC, 52/70, and 9109 IBDV strains, whereas strain VG-313 exhibited a higher identity with the vvIBDV strains.
...
PMID:Molecular characterization of Spanish infectious bursal disease virus field isolates. 1249 46


1 2 Next >>

---